Biomarkers of Traumatic Brain Injury in the Geriatric Population

Traumatic brain injury (TBI) remains a significant cause of morbidity and mortality, and advanced age is an independent predictor of worse outcome. Mortality is nearly double that of younger TBI patients, regardless of injury severity. In addition, geriatric patients are more prone to complications,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current geriatrics reports 2012-09, Vol.1 (3), p.129-134
Hauptverfasser: Rice, Darian, Wang, Kevin K. W., Robicsek, Steven
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 134
container_issue 3
container_start_page 129
container_title Current geriatrics reports
container_volume 1
creator Rice, Darian
Wang, Kevin K. W.
Robicsek, Steven
description Traumatic brain injury (TBI) remains a significant cause of morbidity and mortality, and advanced age is an independent predictor of worse outcome. Mortality is nearly double that of younger TBI patients, regardless of injury severity. In addition, geriatric patients are more prone to complications, have longer hospital stays, and require long-term rehabilitative services, the cost of which can be a significant burden. These observations are often attributed to anatomic and physiologic changes that occur with age, as well as patient comorbidities and the medications required to treat those conditions. Although current diagnostic and treatment guidelines have led to improved outcomes in the general population, data regarding the specific management of geriatric patients remain sparse. The identification and management of TBI has been the focus of both basic science and clinical investigations. Recent advances in molecular biology have identified specific markers of brain cell damage that may offer insight to the nature and progression of injury, lead to improved monitoring and diagnostic capability, and potentially guide therapy. This review highlights some of the latest technology that may pave the way for advanced diagnostic and treatment modalities.
doi_str_mv 10.1007/s13670-012-0022-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2920223207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920223207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c289t-4bec8b9a1ea10681cd16a53bcdb9d95530980d164ae28b50fa74b78a3d09e6b93</originalsourceid><addsrcrecordid>eNp1UMtOwzAQtBBIVKUfwC0SZ8OunYd9g1ZQKlWCQzlbduJAQhsHOzn073EVJLiwl13tzsxqhpBrhFsEKO4C8rwACsgoAGM0OyMzhjmjqUzx_M98SRYhtBBLIGcoZuR-2biD9p_Wh8TVyc7r8aCHpkyWXjddsuna0R-TOA0fNllb3-jBx-ur68d9xLnuilzUeh_s4qfPydvT4271TLcv683qYUtLJuRAU2NLYaRGqxFygWWFuc64KSsjK5llHKSAuEu1ZcJkUOsiNYXQvAJpcyP5nNxMur13X6MNg2rd6Lv4UjHJomvOoIgonFCldyF4W6veN9HfUSGoU1ZqykrFrNQpK5VFDps4IWK7d-t_lf8nfQNrumrZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920223207</pqid></control><display><type>article</type><title>Biomarkers of Traumatic Brain Injury in the Geriatric Population</title><source>ProQuest Central (Alumni Edition)</source><source>ProQuest Central UK/Ireland</source><source>SpringerLink Journals - AutoHoldings</source><source>ProQuest Central</source><creator>Rice, Darian ; Wang, Kevin K. W. ; Robicsek, Steven</creator><creatorcontrib>Rice, Darian ; Wang, Kevin K. W. ; Robicsek, Steven</creatorcontrib><description>Traumatic brain injury (TBI) remains a significant cause of morbidity and mortality, and advanced age is an independent predictor of worse outcome. Mortality is nearly double that of younger TBI patients, regardless of injury severity. In addition, geriatric patients are more prone to complications, have longer hospital stays, and require long-term rehabilitative services, the cost of which can be a significant burden. These observations are often attributed to anatomic and physiologic changes that occur with age, as well as patient comorbidities and the medications required to treat those conditions. Although current diagnostic and treatment guidelines have led to improved outcomes in the general population, data regarding the specific management of geriatric patients remain sparse. The identification and management of TBI has been the focus of both basic science and clinical investigations. Recent advances in molecular biology have identified specific markers of brain cell damage that may offer insight to the nature and progression of injury, lead to improved monitoring and diagnostic capability, and potentially guide therapy. This review highlights some of the latest technology that may pave the way for advanced diagnostic and treatment modalities.</description><identifier>ISSN: 2162-4941</identifier><identifier>ISSN: 2196-7865</identifier><identifier>EISSN: 2162-4941</identifier><identifier>EISSN: 2196-7865</identifier><identifier>DOI: 10.1007/s13670-012-0022-5</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Age ; Baby boomers ; Biomarkers ; Cardiac arrhythmia ; Comorbidity ; Dementia ; Disease prevention ; Edema ; Falls ; Geriatrics ; Geriatrics/Gerontology ; Head injuries ; Hematoma ; Hypertension ; Ischemia ; Medicine ; Medicine &amp; Public Health ; Metabolism ; Mortality ; Neurology ; Older people ; Oxidative stress ; Pain Medicine ; Population ; Psychopharmacology ; Rheumatology ; Section Editor ; Traumatic brain injury ; Traumatic Brain Injury and Dementia (K Wang</subject><ispartof>Current geriatrics reports, 2012-09, Vol.1 (3), p.129-134</ispartof><rights>Springer Science+Business Media, LLC 2012</rights><rights>Springer Science+Business Media, LLC 2012.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c289t-4bec8b9a1ea10681cd16a53bcdb9d95530980d164ae28b50fa74b78a3d09e6b93</citedby><cites>FETCH-LOGICAL-c289t-4bec8b9a1ea10681cd16a53bcdb9d95530980d164ae28b50fa74b78a3d09e6b93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2920223207?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21388,21389,27924,27925,33530,33744,43659,43805,64385,64389,72469</link.rule.ids></links><search><creatorcontrib>Rice, Darian</creatorcontrib><creatorcontrib>Wang, Kevin K. W.</creatorcontrib><creatorcontrib>Robicsek, Steven</creatorcontrib><title>Biomarkers of Traumatic Brain Injury in the Geriatric Population</title><title>Current geriatrics reports</title><addtitle>Curr Tran Geriatr Gerontol Rep</addtitle><description>Traumatic brain injury (TBI) remains a significant cause of morbidity and mortality, and advanced age is an independent predictor of worse outcome. Mortality is nearly double that of younger TBI patients, regardless of injury severity. In addition, geriatric patients are more prone to complications, have longer hospital stays, and require long-term rehabilitative services, the cost of which can be a significant burden. These observations are often attributed to anatomic and physiologic changes that occur with age, as well as patient comorbidities and the medications required to treat those conditions. Although current diagnostic and treatment guidelines have led to improved outcomes in the general population, data regarding the specific management of geriatric patients remain sparse. The identification and management of TBI has been the focus of both basic science and clinical investigations. Recent advances in molecular biology have identified specific markers of brain cell damage that may offer insight to the nature and progression of injury, lead to improved monitoring and diagnostic capability, and potentially guide therapy. This review highlights some of the latest technology that may pave the way for advanced diagnostic and treatment modalities.</description><subject>Age</subject><subject>Baby boomers</subject><subject>Biomarkers</subject><subject>Cardiac arrhythmia</subject><subject>Comorbidity</subject><subject>Dementia</subject><subject>Disease prevention</subject><subject>Edema</subject><subject>Falls</subject><subject>Geriatrics</subject><subject>Geriatrics/Gerontology</subject><subject>Head injuries</subject><subject>Hematoma</subject><subject>Hypertension</subject><subject>Ischemia</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolism</subject><subject>Mortality</subject><subject>Neurology</subject><subject>Older people</subject><subject>Oxidative stress</subject><subject>Pain Medicine</subject><subject>Population</subject><subject>Psychopharmacology</subject><subject>Rheumatology</subject><subject>Section Editor</subject><subject>Traumatic brain injury</subject><subject>Traumatic Brain Injury and Dementia (K Wang</subject><issn>2162-4941</issn><issn>2196-7865</issn><issn>2162-4941</issn><issn>2196-7865</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1UMtOwzAQtBBIVKUfwC0SZ8OunYd9g1ZQKlWCQzlbduJAQhsHOzn073EVJLiwl13tzsxqhpBrhFsEKO4C8rwACsgoAGM0OyMzhjmjqUzx_M98SRYhtBBLIGcoZuR-2biD9p_Wh8TVyc7r8aCHpkyWXjddsuna0R-TOA0fNllb3-jBx-ur68d9xLnuilzUeh_s4qfPydvT4271TLcv683qYUtLJuRAU2NLYaRGqxFygWWFuc64KSsjK5llHKSAuEu1ZcJkUOsiNYXQvAJpcyP5nNxMur13X6MNg2rd6Lv4UjHJomvOoIgonFCldyF4W6veN9HfUSGoU1ZqykrFrNQpK5VFDps4IWK7d-t_lf8nfQNrumrZ</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Rice, Darian</creator><creator>Wang, Kevin K. W.</creator><creator>Robicsek, Steven</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20120901</creationdate><title>Biomarkers of Traumatic Brain Injury in the Geriatric Population</title><author>Rice, Darian ; Wang, Kevin K. W. ; Robicsek, Steven</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c289t-4bec8b9a1ea10681cd16a53bcdb9d95530980d164ae28b50fa74b78a3d09e6b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Age</topic><topic>Baby boomers</topic><topic>Biomarkers</topic><topic>Cardiac arrhythmia</topic><topic>Comorbidity</topic><topic>Dementia</topic><topic>Disease prevention</topic><topic>Edema</topic><topic>Falls</topic><topic>Geriatrics</topic><topic>Geriatrics/Gerontology</topic><topic>Head injuries</topic><topic>Hematoma</topic><topic>Hypertension</topic><topic>Ischemia</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolism</topic><topic>Mortality</topic><topic>Neurology</topic><topic>Older people</topic><topic>Oxidative stress</topic><topic>Pain Medicine</topic><topic>Population</topic><topic>Psychopharmacology</topic><topic>Rheumatology</topic><topic>Section Editor</topic><topic>Traumatic brain injury</topic><topic>Traumatic Brain Injury and Dementia (K Wang</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rice, Darian</creatorcontrib><creatorcontrib>Wang, Kevin K. W.</creatorcontrib><creatorcontrib>Robicsek, Steven</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Current geriatrics reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rice, Darian</au><au>Wang, Kevin K. W.</au><au>Robicsek, Steven</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomarkers of Traumatic Brain Injury in the Geriatric Population</atitle><jtitle>Current geriatrics reports</jtitle><stitle>Curr Tran Geriatr Gerontol Rep</stitle><date>2012-09-01</date><risdate>2012</risdate><volume>1</volume><issue>3</issue><spage>129</spage><epage>134</epage><pages>129-134</pages><issn>2162-4941</issn><issn>2196-7865</issn><eissn>2162-4941</eissn><eissn>2196-7865</eissn><abstract>Traumatic brain injury (TBI) remains a significant cause of morbidity and mortality, and advanced age is an independent predictor of worse outcome. Mortality is nearly double that of younger TBI patients, regardless of injury severity. In addition, geriatric patients are more prone to complications, have longer hospital stays, and require long-term rehabilitative services, the cost of which can be a significant burden. These observations are often attributed to anatomic and physiologic changes that occur with age, as well as patient comorbidities and the medications required to treat those conditions. Although current diagnostic and treatment guidelines have led to improved outcomes in the general population, data regarding the specific management of geriatric patients remain sparse. The identification and management of TBI has been the focus of both basic science and clinical investigations. Recent advances in molecular biology have identified specific markers of brain cell damage that may offer insight to the nature and progression of injury, lead to improved monitoring and diagnostic capability, and potentially guide therapy. This review highlights some of the latest technology that may pave the way for advanced diagnostic and treatment modalities.</abstract><cop>Boston</cop><pub>Springer US</pub><doi>10.1007/s13670-012-0022-5</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2162-4941
ispartof Current geriatrics reports, 2012-09, Vol.1 (3), p.129-134
issn 2162-4941
2196-7865
2162-4941
2196-7865
language eng
recordid cdi_proquest_journals_2920223207
source ProQuest Central (Alumni Edition); ProQuest Central UK/Ireland; SpringerLink Journals - AutoHoldings; ProQuest Central
subjects Age
Baby boomers
Biomarkers
Cardiac arrhythmia
Comorbidity
Dementia
Disease prevention
Edema
Falls
Geriatrics
Geriatrics/Gerontology
Head injuries
Hematoma
Hypertension
Ischemia
Medicine
Medicine & Public Health
Metabolism
Mortality
Neurology
Older people
Oxidative stress
Pain Medicine
Population
Psychopharmacology
Rheumatology
Section Editor
Traumatic brain injury
Traumatic Brain Injury and Dementia (K Wang
title Biomarkers of Traumatic Brain Injury in the Geriatric Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A11%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomarkers%20of%20Traumatic%20Brain%20Injury%20in%20the%20Geriatric%20Population&rft.jtitle=Current%20geriatrics%20reports&rft.au=Rice,%20Darian&rft.date=2012-09-01&rft.volume=1&rft.issue=3&rft.spage=129&rft.epage=134&rft.pages=129-134&rft.issn=2162-4941&rft.eissn=2162-4941&rft_id=info:doi/10.1007/s13670-012-0022-5&rft_dat=%3Cproquest_cross%3E2920223207%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920223207&rft_id=info:pmid/&rfr_iscdi=true